本文選題：Halomonas + elongate��； 參考：《廣東藥學院學報》2016年01期

【摘要】：目的對具有抗腫瘤活性的海洋細菌Halomonas elongate進行次級代謝產物的分離、純化及抗腫瘤活性研究。方法通過大孔吸附樹脂、硅膠、ODS、Sephadex LH-20凝膠柱色譜等分離純化手段,對H.elongate的次級代謝產物進行分離純化;根據(jù)1H NMR譜、13C NMR譜及MS分析,并結合文獻確定結構;采用MTT法對分離得到的次級代謝產物進行活性檢測。結果從海洋細菌H.elongate的發(fā)酵粗提物中分離鑒定3個化合物,分別為胸腺嘧啶-2'-脫氧核苷(1)、環(huán)(L-甘氨酸-L-脯氨酸)二肽(2)、1-(2'-脫氧-β-D-赤式-呋喃戊糖)-1氫-1,2,4-三嗪酮(3),活性檢測結果顯示3個化合物對人肺癌細胞H1299生長活性均無顯著抑制作用(IC5020μmol/L)。結論化合物1~3均為首次從Halomonas中分離得到。
[Abstract]:Objective to isolate and purify the secondary metabolites of marine bacteria Halomonas elongate with anti-tumor activity and to study its anti-tumor activity. Methods the secondary metabolites of H.elongate were separated and purified by macroporous adsorption resin, Sephadex LH-20 gel column chromatography, 1H NMR spectrum, 13C NMR and MS analysis. The activity of secondary metabolites was determined by MTT method. Results three compounds were isolated and identified from the fermented crude extracts of marine bacteria H.elongate. They were thymidine (Thymine) -2ON-deoxynucleoside (1), cyclic L- glycine (L-proline) dipeptidyl (Thyopyrimidine), dipeptidyl, deoxiodo- 尾-D- (1-triazinone) -2-triazinone (H1299). The results of activity test showed that the three compounds had no significant inhibitory effect on the growth activity of human lung cancer cell line H1299 by IC5020 渭 mol 路L ~ (-1) 路L ~ (-1). Conclusion compounds 1 and 3 were isolated from Halomonas for the first time.
【作者單位】： 廣東藥學院中藥學院;國家海洋局第三海洋研究所海洋生物資源遺傳重點實驗室;
【基金】：國家海洋局第三海洋研究所基本科研業(yè)務費專項資金資助項目(2015028) 海洋經濟創(chuàng)新發(fā)展區(qū)域示范專項經費資助項目(GD2012-D01-001)
【分類號】：R915

【相似文獻】

相關期刊論文 前2條

1 王_g博;鄭立;李文;裴月湖;;海洋細菌NJ6-3-1次級代謝產物化學成分的分離與鑒定[J];沈陽藥科大學學報;2010年05期

2 ;[J];;年期

，

本文編號：1920017